These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


213 related items for PubMed ID: 1505143

  • 1. Pharmacokinetic optimisation of angiotensin converting enzyme (ACE) inhibitor therapy.
    Burnier M, Biollaz J.
    Clin Pharmacokinet; 1992 May; 22(5):375-84. PubMed ID: 1505143
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic drug interactions with ACE inhibitors.
    Shionoiri H.
    Clin Pharmacokinet; 1993 Jul; 25(1):20-58. PubMed ID: 8354016
    [Abstract] [Full Text] [Related]

  • 3. Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure.
    Hoyer J, Schulte KL, Lenz T.
    Clin Pharmacokinet; 1993 Mar; 24(3):230-54. PubMed ID: 8462229
    [Abstract] [Full Text] [Related]

  • 4. Drug interactions with ACE inhibitors.
    Breckenridge AM.
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():133-8. PubMed ID: 2674438
    [Abstract] [Full Text] [Related]

  • 5. Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update.
    Song JC, White CM.
    Clin Pharmacokinet; 2002 Jun; 41(3):207-24. PubMed ID: 11929321
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 7. Fosinopril. Clinical pharmacokinetics and clinical potential.
    Shionoiri H, Naruse M, Minamisawa K, Ueda S, Himeno H, Hiroto S, Takasaki I.
    Clin Pharmacokinet; 1997 Jun; 32(6):460-80. PubMed ID: 9195116
    [Abstract] [Full Text] [Related]

  • 8. Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review.
    Kubo SH, Cody RJ.
    Clin Pharmacokinet; 1985 Jun; 10(5):377-91. PubMed ID: 2994938
    [Abstract] [Full Text] [Related]

  • 9. [Angiotensin-converting enzyme inhibitors: recent therapeutic aspect].
    Shionoiri H, Shigemasa T, Takasaki I.
    Nihon Rinsho; 1997 Aug; 55(8):2067-74. PubMed ID: 9284425
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Comparative evaluation of ACE inhibitors: which differences are relevant?].
    Fischler MP, Follath F.
    Schweiz Med Wochenschr; 1999 Jul 27; 129(29-30):1053-60. PubMed ID: 10464907
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Enalapril, a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Vlasses PH, Larijani GE, Conner DP, Ferguson RK.
    Clin Pharm; 1985 Jul 27; 4(1):27-40. PubMed ID: 2982541
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.